Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
25
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Narula Sanjeev | Chief Financial & Bus. Officer | 5 | $0 | $0 | 2026-10-06 |
| Breedlove Robert Charles | Principal Accounting Officer | 13 | $0 | $26.8K | 2026-09-03 |
| Parikh Asit | Director | 37 | $390.2K | $0 | 2026-05-22 |
| Stenhouse Mark | Director | 10 | $0 | $0 | 2026-05-19 |
| Schroeder Theodore R | Director | 3 | $0 | $0 | 2026-05-19 |
| Topper James N | Director, 10% Owner | 15 | $191.9K | $0 | 2026-05-19 |
| KARBE FRANK | Director | 11 | $99.1K | $0 | 2026-05-19 |
| COLA MICHAEL F | Director | 11 | $186.2K | $0 | 2026-05-19 |
| FIELDS HEIDI | Director | 10 | $0 | $0 | 2026-05-19 |
| Basta Steven L | President and CEO | 14 | $0 | $0 | 2026-02-10 |
| Cook Anne Marie | Chief Legal Off. & Corp. Sec. | 7 | $0 | $0 | 2026-02-10 |
| Henderson Molly | CFO and CBO | 28 | $0 | $447.0K | 2025-04-07 |
| Nabulsi Azmi | Chief Operating Officer | 52 | $245.8K | $4.18M | 2025-02-27 |
| Curran Terrie | President and Chief Executive | 26 | $252.9K | $1.25M | 2025-02-27 |
| Socks David A | Director | 63 | $0 | $17.88M | 2024-05-23 |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | 55 | $0 | $58.48M | 2024-01-24 |
| Guzzo Anthony J. | VP, Chief Accounting Officer | 2 | $0 | $0 | 2022-01-19 |
| Yamada Tadataka | Director | 2 | $0 | $0 | 2021-05-21 |
| Kolchinsky Peter | 10% Owner | 1 | $0 | $31.06M | 2021-03-11 |
| Branning Todd P. | Chief Financial Officer | 2 | $0 | $0 | 2021-01-28 |
| Frazier Life Sciences IX, L.P. | 10% Owner | 1 | $0 | $0 | 2020-06-12 |
| RA Capital Healthcare Fund LP | 10% Owner | 1 | $2.92M | $0 | 2020-04-01 |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | 2 | $1.49M | $0 | 2020-03-31 |
| Edwards Jonathan S. | Director | 6 | $20.00M | $0 | 2019-10-29 |
| Heron Patrick J | 10% Owner | 3 | $20.00M | $0 | 2019-10-29 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Narula Sanjeev | Chief Financial & Bus. Offic | F Tax w/h | 2026-10-06 | 2026-10-08 | 13,485 | $6.78 | $91.4K | 214,718 | SEC↗ |
| Breedlove Robert Charles | Principal Accounting Officer | F Tax w/h | 2026-09-03 | 2026-09-08 | 460 | $9.05 | $4.2K | 59,465 | SEC↗ |
| Breedlove Robert Charles | Principal Accounting Officer | F Tax w/h | 2026-09-03 | 2026-09-08 | 460 | $9.05 | $4.2K | 59,465 | SEC↗ |
| Breedlove Robert Charles | Principal Accounting Officer | F Tax w/h | 2026-07-14 | 2026-07-16 | 1,555 | $11.04 | $17.2K | 59,925 | SEC↗ |
| Parikh Asit | Director | G Gift | 2026-05-22 | 2026-05-27 | 28,000 | — | $0 | 24,122 | SEC↗ |
| Parikh Asit | Director | G Gift | 2026-05-22 | 2026-05-27 | 28,000 | — | $0 | 148,500 | SEC↗ |
| Parikh Asit | Director | D To issuer deriv | 2026-05-20 | 2026-05-21 | 17,500 | — | $0 | 0 | SEC↗ |
| Parikh Asit | Director | M Exercise | 2026-05-20 | 2026-05-21 | 17,500 | $4.95 | $86.6K | 52,122 | SEC↗ |
| Schroeder Theodore R | Director | A Award | 2026-05-19 | 2026-05-21 | 24,122 | — | $0 | 45,122 | SEC↗ |
| KARBE FRANK | Director | A Award | 2026-05-19 | 2026-05-21 | 24,122 | — | $0 | 91,622 | SEC↗ |
| COLA MICHAEL F | Director | A Award | 2026-05-19 | 2026-05-21 | 24,122 | — | $0 | 63,920 | SEC↗ |
| FIELDS HEIDI | Director | A Award | 2026-05-19 | 2026-05-21 | 24,122 | — | $0 | 54,122 | SEC↗ |
| Stenhouse Mark | Director | A Award | 2026-05-19 | 2026-05-21 | 24,122 | — | $0 | 54,122 | SEC↗ |
| Topper James N | Director, 10% Owner | A Award | 2026-05-19 | 2026-05-21 | 24,122 | — | $0 | 66,718 | SEC↗ |
| Parikh Asit | Director | A Award | 2026-05-19 | 2026-05-21 | 24,122 | — | $0 | 34,622 | SEC↗ |
| Parikh Asit | Director | G Gift | 2026-03-10 | 2026-03-11 | 40,000 | — | $0 | 10,500 | SEC↗ |
| Parikh Asit | Director | G Gift | 2026-03-10 | 2026-03-11 | 40,000 | — | $0 | 120,500 | SEC↗ |
| Breedlove Robert Charles | Principal Accounting Officer | F Tax w/h | 2026-02-27 | 2026-03-03 | 414 | $12.56 | $5.2K | 61,480 | SEC↗ |
| Breedlove Robert Charles | Principal Accounting Officer | F Tax w/h | 2026-02-27 | 2026-03-03 | 964 | $12.56 | $12.1K | 61,894 | SEC↗ |
| Breedlove Robert Charles | Principal Accounting Officer | A Award | 2026-02-27 | 2026-03-03 | 2,790 | — | $0 | 62,858 | SEC↗ |
| Breedlove Robert Charles | Principal Accounting Officer | A Award | 2026-02-27 | 2026-03-03 | 13,000 | — | $0 | 60,068 | SEC↗ |
| Basta Steven L | President and CEO | F Tax w/h | 2026-02-10 | 2026-02-12 | 6,277 | $12.82 | $80.5K | 373,315 | SEC↗ |
| Basta Steven L | President and CEO | A Award | 2026-02-10 | 2026-02-12 | 12,362 | — | $0 | 379,592 | SEC↗ |
| Cook Anne Marie | Chief Legal Off. & Corp. Sec | F Tax w/h | 2026-02-10 | 2026-02-12 | 1,535 | $12.82 | $19.7K | 88,660 | SEC↗ |
| Cook Anne Marie | Chief Legal Off. & Corp. Sec | A Award | 2026-02-10 | 2026-02-12 | 3,461 | — | $0 | 90,195 | SEC↗ |
| Parikh Asit | Director | G Gift | 2026-01-23 | 2026-01-27 | 80,500 | — | $0 | 80,500 | SEC↗ |
| Parikh Asit | Director | G Gift | 2026-01-23 | 2026-01-27 | 80,500 | — | $0 | 50,500 | SEC↗ |
| Breedlove Robert Charles | Principal Accounting Officer | F Tax w/h | 2026-01-21 | 2026-01-23 | 776 | $13.61 | $10.6K | 47,068 | SEC↗ |
| Parikh Asit | Director | M Exercise deriv | 2026-01-13 | 2026-01-15 | 8,750 | — | $0 | 0 | SEC↗ |
| Parikh Asit | Director | M Exercise | 2026-01-13 | 2026-01-15 | 8,750 | $10.30 | $90.1K | 131,000 | SEC↗ |
| Narula Sanjeev | Chief Financial & Bus. Offic | A Award deriv | 2026-01-02 | 2026-01-02 | 42,848 | — | $0 | 42,848 | SEC↗ |
| Cook Anne Marie | Chief Legal Off. & Corp. Sec | A Award deriv | 2026-01-02 | 2026-01-02 | 67,878 | — | $0 | 67,878 | SEC↗ |
| Basta Steven L | President and CEO | A Award deriv | 2026-01-02 | 2026-01-02 | 226,156 | — | $0 | 221,156 | SEC↗ |
| Narula Sanjeev | Chief Financial & Bus. Offic | A Award | 2026-01-02 | 2026-01-02 | 82,715 | — | $0 | 226,715 | SEC↗ |
| Cook Anne Marie | Chief Legal Off. & Corp. Sec | A Award | 2026-01-02 | 2026-01-02 | 75,345 | — | $0 | 85,012 | SEC↗ |
| Basta Steven L | President and CEO | A Award | 2026-01-02 | 2026-01-02 | 251,034 | — | $0 | 364,820 | SEC↗ |
| Parikh Asit | Director | M Exercise deriv | 2025-12-19 | 2025-12-23 | 8,750 | — | $0 | 8,750 | SEC↗ |
| Parikh Asit | Director | M Exercise | 2025-12-19 | 2025-12-23 | 8,750 | $10.30 | $90.1K | 122,250 | SEC↗ |
| Breedlove Robert Charles | Principal Accounting Officer | F Tax w/h | 2025-12-18 | 2025-12-19 | 230 | $16.28 | $3.7K | 47,844 | SEC↗ |
| Basta Steven L | President and CEO | A Award | 2025-12-17 | 2025-12-19 | 62,038 | — | $0 | 145,288 | SEC↗ |
| Basta Steven L | President and CEO | F Tax w/h | 2025-12-17 | 2025-12-19 | 31,502 | $15.36 | $483.9K | 113,786 | SEC↗ |
| Cook Anne Marie | Chief Legal Off. & Corp. Sec | A Award | 2025-12-17 | 2025-12-19 | 17,370 | — | $0 | 17,370 | SEC↗ |
| Cook Anne Marie | Chief Legal Off. & Corp. Sec | F Tax w/h | 2025-12-17 | 2025-12-19 | 7,703 | $15.36 | $118.3K | 9,667 | SEC↗ |
| Basta Steven L | President and CEO | M Exercise deriv | 2025-11-28 | 2025-12-02 | 90,000 | — | $0 | 180,000 | SEC↗ |
| Basta Steven L | President and CEO | M Exercise | 2025-11-28 | 2025-12-02 | 90,000 | — | $0 | 131,625 | SEC↗ |
| Basta Steven L | President and CEO | F Tax w/h | 2025-11-28 | 2025-12-02 | 48,375 | $15.62 | $755.6K | 83,250 | SEC↗ |
| Breedlove Robert Charles | Principal Accounting Officer | S Sale | 2025-11-03 | 2025-11-05 | 524 | $13.51 | $7.1K | 47,407 | SEC↗ |
| Narula Sanjeev | Chief Financial & Bus. Offic | A Award deriv | 2025-10-06 | 2025-10-07 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Narula Sanjeev | Chief Financial & Bus. Offic | A Award | 2025-10-06 | 2025-10-08 | 144,000 | — | $0 | 144,000 | SEC↗ |
| Basta Steven L | President and CEO | M Exercise deriv | 2025-09-25 | 2025-09-26 | 90,000 | — | $0 | 270,000 | SEC↗ |
| Basta Steven L | President and CEO | F Tax w/h | 2025-09-25 | 2025-09-26 | 48,375 | $11.66 | $564.1K | 41,625 | SEC↗ |
| Basta Steven L | President and CEO | M Exercise | 2025-09-25 | 2025-09-26 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Breedlove Robert Charles | Principal Accounting Officer | S Sale | 2025-09-05 | 2025-09-09 | 461 | $12.09 | $5.6K | 47,931 | SEC↗ |
| Breedlove Robert Charles | Principal Accounting Officer | S Sale | 2025-07-16 | 2025-07-18 | 1,692 | $8.36 | $14.1K | 48,392 | SEC↗ |
| Cook Anne Marie | Chief Legal Off. & Corp. Sec | A Award deriv | 2025-06-23 | 2025-06-24 | 210,000 | — | $0 | 210,000 | SEC↗ |
| Parikh Asit | Director | A Award deriv | 2025-06-03 | 2025-06-05 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Stenhouse Mark | Director | A Award deriv | 2025-06-03 | 2025-06-05 | 17,500 | — | $0 | 17,500 | SEC↗ |
| FIELDS HEIDI | Director | A Award deriv | 2025-06-03 | 2025-06-05 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Topper James N | Director, 10% Owner | A Award deriv | 2025-06-03 | 2025-06-05 | 17,500 | — | $0 | 17,500 | SEC↗ |
| COLA MICHAEL F | Director | A Award deriv | 2025-06-03 | 2025-06-05 | 17,500 | — | $0 | 17,500 | SEC↗ |
| KARBE FRANK | Director | A Award deriv | 2025-06-03 | 2025-06-05 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Parikh Asit | Director | A Award | 2025-06-03 | 2025-06-05 | 10,500 | — | $0 | 113,500 | SEC↗ |
| Stenhouse Mark | Director | A Award | 2025-06-03 | 2025-06-05 | 10,500 | — | $0 | 30,000 | SEC↗ |
| FIELDS HEIDI | Director | A Award | 2025-06-03 | 2025-06-05 | 10,500 | — | $0 | 30,000 | SEC↗ |
| Topper James N | Director, 10% Owner | A Award | 2025-06-03 | 2025-06-05 | 10,500 | — | $0 | 42,596 | SEC↗ |
| COLA MICHAEL F | Director | A Award | 2025-06-03 | 2025-06-05 | 10,500 | — | $0 | 39,798 | SEC↗ |
| KARBE FRANK | Director | A Award | 2025-06-03 | 2025-06-05 | 10,500 | — | $0 | 67,500 | SEC↗ |
| Topper James N | Director | P Buy | 2025-05-21 | 2025-05-23 | 3,780 | $3.86 | $14.6K | 59,403 | SEC↗ |
| Breedlove Robert Charles | Principal Accounting Officer | A Award deriv | 2025-05-19 | 2025-05-21 | 33,000 | — | $0 | 33,000 | SEC↗ |
| Topper James N | Director | P Buy | 2025-05-14 | 2025-05-15 | 6,300 | $3.32 | $20.9K | 55,623 | SEC↗ |
| Topper James N | Director | P Buy | 2025-05-13 | 2025-05-15 | 1,120 | $3.16 | $3.5K | 49,323 | SEC↗ |
| Topper James N | Director | P Buy | 2025-05-12 | 2025-05-13 | 12,601 | $3.04 | $38.3K | 48,203 | SEC↗ |
| Topper James N | Director | P Buy | 2025-05-09 | 2025-05-13 | 33,376 | $3.19 | $106.5K | 33,376 | SEC↗ |
| Topper James N | Director | P Buy | 2025-05-09 | 2025-05-13 | 2,226 | $3.62 | $8.1K | 35,602 | SEC↗ |
| Parikh Asit | Director | P Buy | 2025-05-07 | 2025-05-08 | 5,000 | $2.40 | $12.0K | 95,500 | SEC↗ |
| Parikh Asit | Director | P Buy | 2025-05-06 | 2025-05-08 | 5,000 | $2.60 | $13.0K | 90,500 | SEC↗ |
| Schroeder Theodore R | Director | A Award deriv | 2025-04-16 | 2025-04-16 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Schroeder Theodore R | Director | A Award | 2025-04-16 | 2025-04-16 | 21,000 | — | $0 | 21,000 | SEC↗ |
| Henderson Molly | CFO and CBO | S Sale | 2025-04-07 | 2025-04-08 | 3,678 | $4.55 | $16.7K | 89,868 | SEC↗ |
| Basta Steven L | President and CEO | A Award deriv | 2025-04-03 | 2025-04-03 | 1,085,000 | — | $0 | 1,085,000 | SEC↗ |
| Basta Steven L | President and CEO | A Award deriv | 2025-04-03 | 2025-04-03 | 360,000 | — | $0 | 360,000 | SEC↗ |
| Parikh Asit | Director | P Buy | 2025-03-13 | 2025-03-17 | 10,000 | $4.42 | $44.2K | 85,500 | SEC↗ |
| Nabulsi Azmi | Chief Operating Officer | A Award deriv | 2025-02-27 | 2025-03-03 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Henderson Molly | CFO and CBO | A Award deriv | 2025-02-27 | 2025-03-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Curran Terrie | President and Chief Executiv | A Award deriv | 2025-02-27 | 2025-03-03 | 342,500 | — | $0 | 342,500 | SEC↗ |
| Nabulsi Azmi | Chief Operating Officer | A Award | 2025-02-27 | 2025-03-03 | 79,200 | — | $0 | 312,590 | SEC↗ |
| Henderson Molly | CFO and CBO | A Award | 2025-02-27 | 2025-03-03 | 72,000 | — | $0 | 165,546 | SEC↗ |
| Curran Terrie | President and Chief Executiv | S Sale | 2025-01-21 | 2025-01-23 | 19,109 | $6.59 | $125.9K | 360,465 | SEC↗ |
| Nabulsi Azmi | Chief Operating Officer | S Sale | 2025-01-21 | 2025-01-23 | 7,886 | $6.59 | $52.0K | 233,390 | SEC↗ |
| Henderson Molly | CFO and CBO | S Sale | 2025-01-21 | 2025-01-23 | 6,583 | $6.59 | $43.4K | 93,546 | SEC↗ |
| Henderson Molly | CFO and CBO | S Sale | 2024-12-19 | 2024-12-20 | 1,291 | $8.00 | $10.3K | 98,156 | SEC↗ |
| Nabulsi Azmi | Chief Operating Officer | S Sale | 2024-12-19 | 2024-12-20 | 1,118 | $8.00 | $8.9K | 239,303 | SEC↗ |
| Parikh Asit | Director | P Buy | 2024-12-13 | 2024-12-16 | 10,000 | $8.12 | $81.2K | 75,500 | SEC↗ |
| KARBE FRANK | Director | P Buy | 2024-12-13 | 2024-12-16 | 12,500 | $7.93 | $99.1K | 57,000 | SEC↗ |
| Parikh Asit | Director | M Exercise deriv | 2024-09-10 | 2025-03-21 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Parikh Asit | Director | M Exercise | 2024-09-10 | 2025-03-21 | 7,500 | $11.72 | $87.9K | 93,000 | SEC↗ |
| Curran Terrie | President and Chief Executiv | S Sale | 2024-07-15 | 2024-07-17 | 33,848 | $11.72 | $396.7K | 377,734 | SEC↗ |
| Henderson Molly | CFO and CBO | S Sale | 2024-07-15 | 2024-07-17 | 4,325 | $11.72 | $50.7K | 99,447 | SEC↗ |
| Nabulsi Azmi | Chief Operating Officer | S Sale | 2024-07-15 | 2024-07-17 | 10,901 | $11.72 | $127.8K | 240,421 | SEC↗ |
| Nabulsi Azmi | Chief Operating Officer | A Award | 2024-05-31 | 2024-05-31 | 7,500 | — | $0 | 249,567 | SEC↗ |
| Henderson Molly | CFO and CBO | A Award | 2024-05-31 | 2024-05-31 | 7,500 | — | $0 | 102,763 | SEC↗ |
| KARBE FRANK | Director | A Award | 2024-05-29 | 2024-05-31 | 25,000 | $10.16 | $254.0K | 44,500 | SEC↗ |
| Socks David A | Director | A Award deriv | 2024-05-23 | 2024-05-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Stenhouse Mark | Director | A Award deriv | 2024-05-23 | 2024-05-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| KARBE FRANK | Director | A Award deriv | 2024-05-23 | 2024-05-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| FIELDS HEIDI | Director | A Award deriv | 2024-05-23 | 2024-05-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| COLA MICHAEL F | Director | A Award deriv | 2024-05-23 | 2024-05-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Parikh Asit | Director | A Award deriv | 2024-05-23 | 2024-05-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Topper James N | Director, 10% Owner | A Award deriv | 2024-05-23 | 2024-05-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Socks David A | Director | A Award | 2024-05-23 | 2024-05-24 | 10,500 | — | $0 | 19,500 | SEC↗ |
| Stenhouse Mark | Director | A Award | 2024-05-23 | 2024-05-24 | 10,500 | — | $0 | 19,500 | SEC↗ |
| KARBE FRANK | Director | A Award | 2024-05-23 | 2024-05-24 | 10,500 | — | $0 | 19,500 | SEC↗ |
| FIELDS HEIDI | Director | A Award | 2024-05-23 | 2024-05-24 | 10,500 | — | $0 | 19,500 | SEC↗ |
| COLA MICHAEL F | Director | A Award | 2024-05-23 | 2024-05-24 | 10,500 | — | $0 | 29,298 | SEC↗ |
| Parikh Asit | Director | A Award | 2024-05-23 | 2024-05-24 | 10,500 | — | $0 | 65,500 | SEC↗ |
| Topper James N | Director, 10% Owner | A Award | 2024-05-23 | 2024-05-24 | 10,500 | — | $0 | 32,096 | SEC↗ |
| Henderson Molly | CFO and CBO | S Sale | 2024-04-08 | 2024-04-10 | 3,435 | $11.10 | $38.1K | 95,263 | SEC↗ |
| Curran Terrie | President and Chief Executiv | S Sale | 2024-03-22 | 2024-03-26 | 16,851 | $9.11 | $153.5K | 410,784 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2024-01-24 | 2024-01-25 | 3,703,703 | $8.10 | $30.00M | 3,755,583 | SEC↗ |
| Henderson Molly | CFO and CBO | S Sale | 2024-01-19 | 2024-01-22 | 6,307 | $7.75 | $48.9K | 98,698 | SEC↗ |
| Curran Terrie | President and Chief Executiv | A Award deriv | 2024-01-18 | 2024-01-22 | 475,000 | — | $0 | 475,000 | SEC↗ |
| Nabulsi Azmi | Chief Operating Officer | A Award deriv | 2024-01-18 | 2024-01-22 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Henderson Molly | CFO and CBO | A Award deriv | 2024-01-18 | 2024-01-22 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Henderson Molly | CFO and CBO | S Sale | 2023-11-20 | 2023-11-21 | 2,127 | $7.24 | $15.4K | 103,061 | SEC↗ |
| Parikh Asit | Director | P Buy | 2023-11-08 | 2023-11-08 | 2,500 | $7.80 | $19.5K | 55,000 | SEC↗ |
| Parikh Asit | Director | P Buy | 2023-11-07 | 2023-11-08 | 4,000 | $7.76 | $31.0K | 52,500 | SEC↗ |
| Parikh Asit | Director | P Buy | 2023-11-06 | 2023-11-08 | 1,000 | $8.04 | $8.0K | 48,500 | SEC↗ |
| Curran Terrie | President and Chief Executiv | A Award | 2023-11-01 | 2023-11-03 | 37,500 | — | $0 | 427,171 | SEC↗ |
| Nabulsi Azmi | Chief Operating Officer | A Award | 2023-11-01 | 2023-11-03 | 32,500 | — | $0 | 242,067 | SEC↗ |
| Henderson Molly | CFO and CBO | S Sale | 2023-11-01 | 2023-11-03 | 11,681 | $8.95 | $104.5K | 105,188 | SEC↗ |
| Henderson Molly | CFO and CBO | S Sale | 2023-11-01 | 2023-11-03 | 811 | $7.80 | $6.3K | 116,869 | SEC↗ |
| Henderson Molly | CFO and CBO | A Award | 2023-11-01 | 2023-11-03 | 22,500 | — | $0 | 117,680 | SEC↗ |
| Nabulsi Azmi | Chief Operating Officer | D To issuer deriv | 2023-07-14 | 2023-07-17 | 70,000 | — | $0 | 0 | SEC↗ |
| Nabulsi Azmi | Chief Operating Officer | D To issuer deriv | 2023-07-14 | 2023-07-17 | 150,000 | — | $0 | 0 | SEC↗ |
| Curran Terrie | President and Chief Executiv | D To issuer deriv | 2023-07-14 | 2023-07-17 | 175,000 | — | $0 | 0 | SEC↗ |
| Curran Terrie | President and Chief Executiv | D To issuer deriv | 2023-07-14 | 2023-07-17 | 225,000 | — | $0 | 0 | SEC↗ |
| Nabulsi Azmi | Chief Operating Officer | A Award | 2023-07-14 | 2023-07-17 | 110,000 | — | $0 | 209,567 | SEC↗ |
| Curran Terrie | President and Chief Executiv | A Award | 2023-07-14 | 2023-07-17 | 200,000 | — | $0 | 389,671 | SEC↗ |
| Henderson Molly | CFO and CBO | A Award | 2023-07-14 | 2023-07-17 | 25,000 | $1.00 | $25.0K | 95,180 | SEC↗ |
| Henderson Molly | CFO and CBO | A Award | 2023-07-14 | 2023-07-21 | 25,000 | — | $0 | 95,180 | SEC↗ |
| Parikh Asit | Director | D To issuer deriv | 2023-06-02 | 2023-06-05 | 15,000 | — | $0 | 0 | SEC↗ |
| Henderson Molly | CFO and CBO | S Sale | 2023-06-02 | 2023-06-05 | 1,960 | $11.41 | $22.4K | 68,506 | SEC↗ |
| Parikh Asit | Director | A Award | 2023-06-02 | 2023-06-05 | 15,000 | $7.40 | $111.0K | 47,500 | SEC↗ |
| COLA MICHAEL F | Director | A Award deriv | 2023-05-25 | 2023-05-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KARBE FRANK | Director | A Award deriv | 2023-05-25 | 2023-05-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| FIELDS HEIDI | Director | A Award deriv | 2023-05-25 | 2023-05-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Parikh Asit | Director | A Award deriv | 2023-05-25 | 2023-05-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Socks David A | Director | A Award deriv | 2023-05-25 | 2023-05-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Stenhouse Mark | Director | A Award deriv | 2023-05-25 | 2023-05-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Topper James N | Director, 10% Owner | A Award deriv | 2023-05-25 | 2023-05-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| COLA MICHAEL F | Director | A Award | 2023-05-25 | 2023-05-30 | 9,000 | — | $0 | 18,798 | SEC↗ |
| KARBE FRANK | Director | A Award | 2023-05-25 | 2023-05-30 | 9,000 | — | $0 | 9,000 | SEC↗ |
| FIELDS HEIDI | Director | A Award | 2023-05-25 | 2023-05-30 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Parikh Asit | Director | A Award | 2023-05-25 | 2023-05-30 | 9,000 | — | $0 | 32,500 | SEC↗ |
| Socks David A | Director | A Award | 2023-05-25 | 2023-05-30 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Stenhouse Mark | Director | A Award | 2023-05-25 | 2023-05-30 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Topper James N | Director, 10% Owner | A Award | 2023-05-25 | 2023-05-30 | 9,000 | — | $0 | 21,596 | SEC↗ |
| Henderson Molly | CFO and CBO | S Sale | 2023-05-22 | 2023-05-23 | 2,110 | $12.87 | $27.2K | 70,466 | SEC↗ |
| Nabulsi Azmi | Chief Operating Officer | P Buy | 2023-04-11 | 2023-04-11 | 10,000 | $8.26 | $82.6K | 99,567 | SEC↗ |
| Parikh Asit | Director | P Buy | 2023-04-10 | 2023-04-11 | 1,000 | $7.55 | $7.5K | 23,500 | SEC↗ |
| Henderson Molly | CFO and CBO | S Sale | 2023-04-06 | 2023-04-07 | 3,439 | $7.27 | $25.0K | 72,576 | SEC↗ |
| Curran Terrie | President and Chief Executiv | P Buy | 2023-04-06 | 2023-04-07 | 12,919 | $7.82 | $101.0K | 188,290 | SEC↗ |
| Curran Terrie | President and Chief Executiv | S Sale | 2023-03-01 | 2023-03-03 | 1,436 | $8.54 | $12.3K | 175,371 | SEC↗ |
| Henderson Molly | CFO and CBO | S Sale | 2023-03-01 | 2023-03-03 | 2,032 | $8.53 | $17.3K | 76,015 | SEC↗ |
| Parikh Asit | Director | P Buy | 2023-02-13 | 2023-02-14 | 5,000 | $7.73 | $38.6K | 22,500 | SEC↗ |
| Curran Terrie | President and Chief Executiv | S Sale | 2023-01-20 | 2023-01-20 | 5,821 | $8.20 | $47.7K | 176,807 | SEC↗ |
| Henderson Molly | CFO and CBO | A Award deriv | 2023-01-19 | 2023-01-20 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Nabulsi Azmi | Chief Operating Officer | A Award deriv | 2023-01-19 | 2023-01-20 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Curran Terrie | President and Chief Executiv | A Award deriv | 2023-01-19 | 2023-01-20 | 162,500 | — | $0 | 162,500 | SEC↗ |
| Henderson Molly | CFO and CBO | A Award | 2023-01-19 | 2023-01-20 | 33,000 | — | $0 | 78,047 | SEC↗ |
| Nabulsi Azmi | Chief Operating Officer | A Award | 2023-01-19 | 2023-01-20 | 45,000 | — | $0 | 89,567 | SEC↗ |
| Curran Terrie | President and Chief Executiv | A Award | 2023-01-19 | 2023-01-20 | 97,500 | — | $0 | 182,628 | SEC↗ |
| Parikh Asit | Director | P Buy | 2023-01-12 | 2023-01-12 | 5,000 | $7.00 | $35.0K | 17,500 | SEC↗ |
| Curran Terrie | President and Chief Executiv | S Sale | 2022-11-21 | 2022-11-23 | 1,526 | $9.60 | $14.6K | 83,720 | SEC↗ |
| Henderson Molly | CFO and CBO | S Sale | 2022-11-21 | 2022-11-23 | 2,159 | $9.60 | $20.7K | 43,341 | SEC↗ |
| Topper James N | Director, 10% Owner | A Award deriv | 2022-09-22 | 2022-09-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Nabulsi Azmi | Chief Operating Officer | A Award | 2022-09-01 | 2022-09-02 | 7,500 | — | $0 | 41,971 | SEC↗ |
| Curran Terrie | President and Chief Executiv | A Award | 2022-09-01 | 2022-09-02 | 7,500 | — | $0 | 85,246 | SEC↗ |
| Henderson Molly | CFO and CBO | A Award | 2022-09-01 | 2022-09-02 | 7,500 | — | $0 | 45,500 | SEC↗ |
| COLA MICHAEL F | Director | A Award deriv | 2022-05-25 | 2022-05-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KARBE FRANK | Director | A Award deriv | 2022-05-25 | 2022-05-27 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FIELDS HEIDI | Director | A Award deriv | 2022-05-25 | 2022-05-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Parikh Asit | Director | A Award deriv | 2022-05-25 | 2022-05-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Socks David A | Director | A Award deriv | 2022-05-25 | 2022-05-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Stenhouse Mark | Director | A Award deriv | 2022-05-25 | 2022-05-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Curran Terrie | President and Chief Executiv | A Award | 2022-05-19 | 2022-05-20 | 12,000 | — | $0 | 76,595 | SEC↗ |
| Henderson Molly | CFO and CBO | A Award | 2022-05-19 | 2022-05-20 | 12,000 | — | $0 | 38,000 | SEC↗ |
| Nabulsi Azmi | Chief Operating Officer | A Award | 2022-05-19 | 2022-05-20 | 12,000 | — | $0 | 33,378 | SEC↗ |
| Nabulsi Azmi | Chief Operating Officer | P Buy | 2022-05-16 | 2022-05-16 | 20,000 | $8.16 | $163.2K | 785,700 | SEC↗ |
| Henderson Molly | CFO and CBO | P Buy | 2022-05-13 | 2022-05-16 | 6,000 | — | $0 | 26,000 | SEC↗ |
| Curran Terrie | President and Chief Executiv | P Buy | 2022-05-13 | 2022-05-16 | 20,500 | $7.41 | $151.9K | 64,595 | SEC↗ |
| Parikh Asit | Director | P Buy | 2022-05-12 | 2022-05-16 | 12,500 | $8.00 | $100.0K | 12,500 | SEC↗ |
| KARBE FRANK | Director | A Award deriv | 2022-04-25 | 2022-04-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Henderson Molly | CFO and CBO | A Award deriv | 2022-04-05 | 2022-04-06 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Henderson Molly | CFO and CBO | A Award | 2022-04-05 | 2022-04-06 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | X Exercise deriv | 2022-03-14 | 2022-03-16 | 7,359,304 | — | $0 | 0 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2022-03-14 | 2022-03-16 | 18 | $19.00 | $342 | 7,459,286 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | X Exercise | 2022-03-14 | 2022-03-16 | 7,359,304 | — | $0 | 7,459,304 | SEC↗ |
| Curran Terrie | President and Chief Executiv | A Award deriv | 2022-01-19 | 2022-01-21 | 206,250 | — | $0 | 206,250 | SEC↗ |
| Guzzo Anthony J. | VP, Chief Accounting Officer | A Award deriv | 2022-01-19 | 2022-01-21 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Nabulsi Azmi | Chief Operating Officer | A Award deriv | 2022-01-19 | 2022-01-21 | 97,500 | — | $0 | 97,500 | SEC↗ |
| Curran Terrie | President and Chief Executiv | A Award | 2022-01-19 | 2022-01-21 | 41,250 | — | $0 | 44,095 | SEC↗ |
| Guzzo Anthony J. | VP, Chief Accounting Officer | A Award | 2022-01-19 | 2022-01-21 | 6,000 | — | $0 | 8,399 | SEC↗ |
| Nabulsi Azmi | Chief Operating Officer | A Award | 2022-01-19 | 2022-01-21 | 19,500 | — | $0 | 21,378 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | X Exercise deriv | 2021-11-04 | 2021-11-08 | 228,696 | — | $0 | 7,359,304 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-11-04 | 2021-11-08 | 1,000,000 | $20.85 | $20.85M | 100,000 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | X Exercise | 2021-11-04 | 2021-11-08 | 228,696 | — | $0 | 1,100,001 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-11-04 | 2021-11-08 | 1 | $19.00 | $19 | 1,100,000 | SEC↗ |
| Socks David A | Director | S Sale | 2021-10-08 | 2021-10-08 | 2,529 | $32.05 | $81.1K | 1,211,346 | SEC↗ |
| Socks David A | Director | S Sale | 2021-10-07 | 2021-10-08 | 15,471 | $32.66 | $505.3K | 1,213,875 | SEC↗ |
| Socks David A | Director | S Sale | 2021-09-22 | 2021-09-23 | 4,100 | $32.06 | $131.4K | 1,229,346 | SEC↗ |
| Socks David A | Director | S Sale | 2021-09-21 | 2021-09-23 | 324 | $33.31 | $10.8K | 1,233,446 | SEC↗ |
| Socks David A | Director | S Sale | 2021-09-21 | 2021-09-23 | 13,576 | $32.79 | $445.2K | 1,233,770 | SEC↗ |
| Socks David A | Director | S Sale | 2021-08-16 | 2021-08-18 | 4,209 | $30.47 | $128.2K | 1,261,137 | SEC↗ |
| Socks David A | Director | S Sale | 2021-08-16 | 2021-08-18 | 13,791 | $31.49 | $434.3K | 1,247,346 | SEC↗ |
| Parikh Asit | Director | A Award deriv | 2021-07-13 | 2021-07-14 | 7,500 | — | $0 | 7,500 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-07-07 | 2021-07-09 | 2,609 | $35.05 | $91.4K | 871,305 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-07-02 | 2021-07-06 | 100 | $35.01 | $3.5K | 873,914 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-07-01 | 2021-07-06 | 8,226 | $35.16 | $289.2K | 874,014 | SEC↗ |
| Socks David A | Director | S Sale | 2021-06-29 | 2021-06-29 | 13,960 | $34.00 | $474.6K | 1,260,945 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-06-28 | 2021-06-29 | 370 | $35.08 | $13.0K | 882,240 | SEC↗ |
| Socks David A | Director | S Sale | 2021-06-28 | 2021-06-29 | 156 | $35.09 | $5.5K | 1,274,905 | SEC↗ |
| Socks David A | Director | S Sale | 2021-06-28 | 2021-06-29 | 25,884 | $34.07 | $881.9K | 1,275,061 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-06-25 | 2021-06-29 | 1,250 | $36.07 | $45.1K | 882,610 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-06-25 | 2021-06-29 | 22,881 | $35.46 | $811.4K | 883,860 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-06-24 | 2021-06-25 | 10,848 | $35.14 | $381.2K | 906,741 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-06-23 | 2021-06-25 | 200 | $35.00 | $7.0K | 917,589 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-06-22 | 2021-06-23 | 100 | $35.00 | $3.5K | 917,789 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-06-21 | 2021-06-23 | 9,294 | $35.31 | $328.2K | 917,889 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-06-18 | 2021-06-21 | 5,398 | $35.13 | $189.6K | 927,183 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-06-17 | 2021-06-21 | 3,305 | $35.08 | $115.9K | 932,581 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-06-14 | 2021-06-16 | 2,826 | $35.06 | $99.1K | 935,886 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-06-10 | 2021-06-11 | 2,102 | $35.14 | $73.9K | 938,712 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-06-09 | 2021-06-11 | 1,191 | $35.28 | $42.0K | 940,814 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-06-08 | 2021-06-09 | 100 | $35.00 | $3.5K | 942,005 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-06-07 | 2021-06-09 | 2,264 | $35.05 | $79.4K | 942,105 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-06-02 | 2021-06-04 | 4,300 | $35.18 | $151.3K | 944,369 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-06-01 | 2021-06-02 | 7,244 | $35.55 | $257.5K | 952,636 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-06-01 | 2021-06-02 | 3,967 | $36.20 | $143.6K | 948,669 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-05-28 | 2021-06-02 | 2,668 | $36.40 | $97.1K | 961,984 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-05-28 | 2021-06-02 | 2,104 | $37.55 | $79.0K | 959,880 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-05-28 | 2021-06-02 | 4,133 | $35.37 | $146.2K | 964,652 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-05-27 | 2021-05-28 | 2,279 | $37.55 | $85.6K | 968,785 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-05-27 | 2021-05-28 | 6,174 | $36.99 | $228.4K | 971,064 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-05-26 | 2021-05-28 | 7,469 | $36.45 | $272.2K | 982,127 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-05-26 | 2021-05-28 | 4,889 | $36.92 | $180.5K | 977,238 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-05-25 | 2021-05-26 | 548 | $36.59 | $20.1K | 989,596 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-05-25 | 2021-05-26 | 10,399 | $36.16 | $376.0K | 990,144 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-05-24 | 2021-05-26 | 8,911 | $35.58 | $317.1K | 1,002,226 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-05-24 | 2021-05-26 | 1,683 | $36.10 | $60.8K | 1,000,543 | SEC↗ |
| Yamada Tadataka | Director | A Award deriv | 2021-05-21 | 2021-05-24 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Socks David A | Director | A Award deriv | 2021-05-21 | 2021-05-24 | 12,500 | — | $0 | 12,500 | SEC↗ |
| COLA MICHAEL F | Director | A Award deriv | 2021-05-21 | 2021-05-24 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Stenhouse Mark | Director | A Award deriv | 2021-05-21 | 2021-05-24 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Parikh Asit | Director | A Award deriv | 2021-05-21 | 2021-05-24 | 12,500 | — | $0 | 12,500 | SEC↗ |
| FIELDS HEIDI | Director | A Award deriv | 2021-05-21 | 2021-05-24 | 12,500 | — | $0 | 12,500 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-05-21 | 2021-05-24 | 11,648 | $35.74 | $416.3K | 1,011,137 | SEC↗ |
| Socks David A | Director | S Sale | 2021-05-20 | 2021-05-21 | 899 | $33.76 | $30.4K | 1,303,528 | SEC↗ |
| Socks David A | Director | S Sale | 2021-05-20 | 2021-05-21 | 2,278 | $34.93 | $79.6K | 1,301,250 | SEC↗ |
| Socks David A | Director | S Sale | 2021-05-20 | 2021-05-21 | 305 | $35.27 | $10.8K | 1,300,945 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-05-20 | 2021-05-24 | 7,098 | $35.10 | $249.1K | 1,022,785 | SEC↗ |
| Socks David A | Director | S Sale | 2021-05-19 | 2021-05-21 | 16,020 | $32.78 | $525.1K | 1,307,656 | SEC↗ |
| Socks David A | Director | S Sale | 2021-05-19 | 2021-05-21 | 3,229 | $33.38 | $107.8K | 1,304,427 | SEC↗ |
| Socks David A | Director | S Sale | 2021-05-19 | 2021-05-21 | 17,269 | $31.96 | $551.9K | 1,323,676 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-05-14 | 2021-05-18 | 100 | $35.00 | $3.5K | 1,029,883 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-05-13 | 2021-05-14 | 100 | $35.33 | $3.5K | 1,029,983 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-05-12 | 2021-05-14 | 905 | $36.06 | $32.6K | 1,030,083 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-05-12 | 2021-05-14 | 10,871 | $35.39 | $384.7K | 1,030,988 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-05-07 | 2021-05-11 | 1,011 | $35.03 | $35.4K | 1,041,859 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-05-06 | 2021-05-07 | 202 | $35.01 | $7.1K | 1,042,870 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-05-05 | 2021-05-07 | 6,936 | $35.14 | $243.7K | 1,043,072 | SEC↗ |
| Nabulsi Azmi | Chief Operating Officer | S Sale | 2021-05-04 | 2021-05-04 | 1,968 | $36.15 | $71.1K | 768,189 | SEC↗ |
| Nabulsi Azmi | Chief Operating Officer | S Sale | 2021-05-04 | 2021-05-04 | 1,400 | $37.09 | $51.9K | 766,789 | SEC↗ |
| Nabulsi Azmi | Chief Operating Officer | S Sale | 2021-05-04 | 2021-05-04 | 1,089 | $37.86 | $41.2K | 765,700 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-05-04 | 2021-05-05 | 11,070 | $35.50 | $393.0K | 1,058,298 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-05-04 | 2021-05-05 | 4,690 | $36.21 | $169.8K | 1,053,608 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-05-04 | 2021-05-05 | 3,500 | $37.47 | $131.1K | 1,050,108 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-05-04 | 2021-05-05 | 100 | $38.53 | $3.9K | 1,050,008 | SEC↗ |
| Nabulsi Azmi | Chief Operating Officer | S Sale | 2021-05-03 | 2021-05-04 | 5,753 | $38.59 | $222.0K | 770,157 | SEC↗ |
| Nabulsi Azmi | Chief Operating Officer | S Sale | 2021-05-03 | 2021-05-04 | 4,290 | $37.85 | $162.4K | 775,910 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-05-03 | 2021-05-05 | 203 | $39.06 | $7.9K | 1,069,368 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-05-03 | 2021-05-05 | 11,272 | $38.45 | $433.4K | 1,069,571 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | S Sale | 2021-05-03 | 2021-05-05 | 3,157 | $37.60 | $118.7K | 1,080,843 | SEC↗ |
| Socks David A | Director | S Sale | 2021-04-06 | 2021-04-07 | 6,795 | $38.03 | $258.4K | 1,340,945 | SEC↗ |
| Socks David A | Director | S Sale | 2021-04-06 | 2021-04-07 | 6,328 | $37.37 | $236.5K | 1,347,740 | SEC↗ |
| Socks David A | Director | S Sale | 2021-04-06 | 2021-04-07 | 3,359 | $35.97 | $120.8K | 1,354,068 | SEC↗ |
| Socks David A | Director | S Sale | 2021-04-06 | 2021-04-07 | 1,400 | $34.96 | $48.9K | 1,357,427 | SEC↗ |
| Nabulsi Azmi | Chief Operating Officer | S Sale | 2021-04-05 | 2021-04-05 | 4,252 | $35.66 | $151.6K | 785,301 | SEC↗ |
| Nabulsi Azmi | Chief Operating Officer | S Sale | 2021-04-05 | 2021-04-05 | 4,316 | $36.37 | $157.0K | 780,985 | SEC↗ |
| Nabulsi Azmi | Chief Operating Officer | S Sale | 2021-04-05 | 2021-04-05 | 785 | $37.11 | $29.1K | 780,200 | SEC↗ |
| Socks David A | Director | S Sale | 2021-04-05 | 2021-04-07 | 1,730 | $37.15 | $64.3K | 1,358,827 | SEC↗ |
| Socks David A | Director | S Sale | 2021-04-05 | 2021-04-07 | 7,769 | $36.40 | $282.8K | 1,360,557 | SEC↗ |
| Socks David A | Director | S Sale | 2021-04-05 | 2021-04-07 | 12,619 | $35.69 | $450.4K | 1,368,326 | SEC↗ |
| Nabulsi Azmi | Chief Operating Officer | S Sale | 2021-04-01 | 2021-04-05 | 1,742 | $38.14 | $66.4K | 789,553 | SEC↗ |
| Nabulsi Azmi | Chief Operating Officer | S Sale | 2021-04-01 | 2021-04-05 | 3,405 | $37.28 | $126.9K | 791,295 | SEC↗ |
| Curran Terrie | President and Chief Executiv | M Exercise deriv | 2021-03-22 | 2021-03-23 | 11,513 | — | $0 | 855,687 | SEC↗ |
| Curran Terrie | President and Chief Executiv | M Exercise | 2021-03-22 | 2021-03-23 | 11,513 | $6.95 | $80.0K | 11,513 | SEC↗ |
| Curran Terrie | President and Chief Executiv | S Sale | 2021-03-22 | 2021-03-23 | 10,373 | $43.24 | $448.5K | 1,140 | SEC↗ |
| Curran Terrie | President and Chief Executiv | S Sale | 2021-03-22 | 2021-03-23 | 1,140 | $44.08 | $50.3K | 0 | SEC↗ |
| Socks David A | Director | S Sale | 2021-03-12 | 2021-03-12 | 500 | $46.67 | $23.3K | 1,380,945 | SEC↗ |